Board of Directors
Co-Chair, Secretary Jay Ash
Co-Chair, Secretary Kristen Lepore
Secretary of the Executive Office of Housing and Economic Development
Jay Ash serves as the Secretary of Housing and Economic Development for the Commonwealth of Massachusetts. Secretary Ash is responsible for directing and executing Governor Charlie Baker’s agenda on housing and community development, job creation, business development, consumer affairs, and business regulation. He previously served as the city manager in his native Chelsea, a position he held from 2000 to 2014. In Chelsea, Secretary Ash’s leadership produced both economic expansion and fiscal stability. He grew the city’s housing stock by over ten percent, expanded its commercial base with two dozen major projects, led all Gateway Cities with a 15% increase in new employment, developed 10 new parks, secured five credit rating increases, and won two All-America City designations for Chelsea. Secretary Ash has led statewide initiatives on health insurance, youth violence, transportation infrastructure and expanded gaming in Massachusetts. He previously served as co-founder and vice-chair of the Metropolitan Mayors Coalition, as past president of the Metropolitan Area Planning Council, as a board member of the public policy think tank MassINC, the staff director to the Massachusetts House Majority Leader, and as an elected trustee of his alma mater, Clark University.
Secretary of the Executive Office for Administration and Finance
Kristen Lepore was sworn in as Secretary of the Executive Office for Administration and Finance under Governor Charlie Baker in January 2015. In her role, Secretary Lepore is in charge of formulating the governor’s budget plan, providing guidance on the economy, and implementing state government’s operating and capital budgets. She also manages the state’s administrative agencies, including revenue collection, information technology, human resources, procurement, and state facilities.
She was previously Vice President of Government Affairs at Associated Industries of Massachusetts (AIM). As Vice President, she was responsible for AIM’s health care agenda and advocated for policies to lower the cost of health care in Massachusetts. She also worked on education and workforce development issues on behalf of the association.
Immediately prior to joining AIM, she served as Policy Director on Charlie Baker’s 2010 gubernatorial campaign. In addition, she was appointed by President Bush to serve as the New England regional representative for the U.S. Department of Education where she advocated the President’s education agenda. Prior to her federal appointment, she served as Deputy Chief of Staff to Governor Paul Cellucci; Director of Fiscal Policy for the Executive Office for Administration and Finance and Assistant Executive Director of the Massachusetts Port Authority.
Kristen holds a bachelor’s degree in political science from Suffolk University and a master’s degree in public administration from Suffolk’s Sawyer School of Management.
Gary Paul Kearney, M.D.
President, Longwood Urological Associates
Gary Kearney is a native of Piedmont, California. He received his Bachelor of Arts Degree with honors from Northwestern University in 1961 and his Doctor of Medicine Degree in 1965 at the University of California, San Francisco. On completion of active duty in the United States Navy during the Vietnam conflict he trained as a Urological Surgeon at the Harvard Program of Urology, Longwood area. Since 1973 he has been on the staff of the Brigham & Women’s Hospital, Beth Israel Deaconess Medical, and New England Baptist Hospital where he was President of the Medical Staff, Chief of Urology, and Vice Chairman of the Department of Surgery. Dr. Kearney currently serves as President of Longwood Urological Associates in Boston.
In 1999 Dr Kearney retired as a Captain of the United States Naval Reserve, having served since 1961.
He served as Treasurer of the Theodore Roosevelt Association and currently serves on the Executive Committee. Gary Kearney is also a Trustee of Rogerson Communities, Past Chairman of the Development Committee, a nonprofit organization devoted to affordable housing and services for elders. He is also Vice Chairman and Trustee of the USS Constitution Museum.
Dr. Kearney is an avid aviation enthusiast with an airline pilot rating who enjoys swimming, photography and traveling. His wife, Susan can be found lovingly restoring our “final resting place “to its original historic appearance when she is not out in the garden pulling weeds. They currently reside on weekends in Duxbury and have four adult children, Michael, Alison, Shanon and Christian and six grand children, Anders, Niall, Owen, Laurel, Thea and Sam
President, University of Massachusetts
Marty Meehan, the 27th president of the University of Massachusetts, is the first undergraduate alumnus to lead the system. He was named to the presidency after eight successful years as chancellor of the University of Massachusetts Lowell, where he propelled that institution forward by every important measure of higher education. During his tenure, UMass Lowell achieved record growth in enrollment, student retention and funding for research and scholarships. The campus underwent a stunning physical transformation with new academic buildings and residence halls, upgraded academic and research facilities, and enhanced student activity spaces.
While chancellor, he was honored by the Lura Smith Fund with the Living the Dream Award in 2015 for embracing the dream of Dr. Martin Luther King Jr. through his faith and commitment to social justice. In 2014, he received the Association of College Unions International (ACUI) President of the Year Award at the organization’s 100th anniversary celebration and the Robert H. (Tex) McClain, Jr. Distinguished Public Administrator Award from the Massachusetts Chapter of the American Society of Public Administration. He received the Chief Executive Leadership award from the Council for Advancement and Support of Education (CASE) at the annual District I program in 2012.
A former congressman, President Meehan represented the 5th Congressional District of Massachusetts in the U.S. House of Representatives from 1993 to 2007, where he served on the House Armed Services and Judiciary committees. Widely respected as a reformer, he established a national reputation for his legislative leadership in transforming campaign finance laws and protecting the public from the health risks of tobacco use. Previously, he served as Massachusetts’ deputy secretary of state for securities and corporations and he was the first assistant district attorney of Middlesex County.
President Meehan graduated cum laude from UMass Lowell in 1978 with a degree in education and political science. He earned a master’s degree in public administration from Suffolk University in 1981 and a juris doctor from Suffolk University Law School in 1986. He holds honorary degrees from Suffolk University, Green Mountain College in Vermont and Shenkar College of Engineering & Design in Israel.
Founder, BioInnovation Capital and Lab Central
Peter is currently President, BioInnovation, LLC, a Cambridge, MA based provider of start-up capital and services to life sciences companies. For the past three decades, Peter has devoted his life to the amazing world of early stage company formation, funding and growth as an equity investor in over 30 companies. For the past 8 years, Peter has played a major role in the greater Boston/Cambridge healthcare start-up community. At MassChallenge, he has been the healthcare/life sciences ‘Champion’ from the outset, managing that vertical for the Boston accelerator. He is also one of three co-founders of LabCentral, Inc, a new not-for-profit for companies who need lab space in Kendall Sq. He is the founder of several start-ups, is a member of MassMedicalAngels, and is a reviewer for the Massachusetts Life Sciences Center Accelerator Loan program and for several other business plan competitions. Peter was a General Partner at Ampersand Ventures from 1988-2006 (now Sr. Advisor) and co-led the establishment of their life sciences franchise. The sectors where he has invested extensively include tools, devices, diagnostics, and therapeutics.
At Ampersand, Peter provided the first institutional capital and was a Director in two dozen companies including; ACLARA Biosciences (IPO), Cyclis Pharmaceuticals (Chairman, sold to Arqule), Huntington Laboratories (Chairman, sold to EcoLab), NOVEX (Chairman, sold to Invitrogen), Panacos Pharmaceuticals (Chairman, public/reverse merger and PIPE with Vitex), Protein Ingredient Technologies (Chairman, sold to Associated British Foods). In 2006, Peter co-founded and was President and CEO of Cequent Pharmaceuticals, Inc (Cambridge, MA) which was sold to Marina Biotech (NSDQ: MRNA) in July, 2010. He has since invested in 12 local start-ups including Boston Heart Dx (Chairman) Klio Health, Veritas Genetics, 5G Bio, Deltix, Nova Molecular, Hope Dx, BioEssences, and AbVitro.
Prior to Ampersand, Peter was head of worldwide R&D for AMAX Inc, a Fortune 50 industrial company.
Peter holds a B.S. and an M.S. degree from Columbia University.
CEO and Founder, Empiriko
Pam Randhawa is Founder and CEO of Empiriko, an integrated precision medicine company focused on early disease detection, prognosis, prediction and ongoing therapeutic monitoring.
Pam has 20 years of experience in the healthcare and life sciences industries with expertise ranging from policy, corporate strategy, product development, analytics and marketing for Fortune 500 companies, startups and government. Prior to founding Empiriko, Pam co-founded AgroGreen Biofuels, an alternative biofuels technology company from plant waste.The company’s patented synthetic liver technology (Biomimiks™) provides a platform for analyzing the liver’s metabolic reactions to drugs, food and other chemical compounds – serving as a foundation for the company’s diagnostic device, Personalized Metabolic Fingerprint™ (PMF).
Previously, Pam served as VP of Strategic Development at Sermo, the largest Physician Online Community in the US, where she was responsible for identifying and developing new markets in the areas of clinical development, analytics and international expansion. Before joining Sermo, she served as VP of Global Marketing at Phase Forward (acquired by Oracle), a leader in Electronic Data Capture (EDC), management and drug safety for clinical trials, where she was responsible for the planning and execution of the company’s global marketing and product strategy. Previously, Pam was Director of Analytical Development at McKesson Corporation, where she effectively developed healthcare products that leveraged healthcare longitudinal data to assess the effectiveness of various therapies, disease severity, healthcare costs, and quality of care provided to healthcare plan members. She also served as an independent consultant to the State of Ohio, Department of Health, where she led a statewide taskforce focusing on the Health Status of Ohioans for the State Health Plan, and developed a 5-point plan to improve public health in Ohio.
Ms. Randhawa holds a Bachelors Degree in economics from the University of Rajasthan, India, and received a Masters Degree from the Heinz School of Public Policy and Management at Carnegie-Mellon University.
Lydia Villa-Komaroff, Ph.D.
FormerCEO & CSO, Cytonome/ST
Lydia Villa-Komaroff is a Board member and co-founder of Cytonome/ST, LLC (“Cytonome”), a company developing and manufacturing purpose-built cell sorters, including the first optical cell sorter capable of supporting rapid, sterile sorting of human cells for therapeutic use. She began her research career under the tutelage of David Baltimore and Harvey Lodish at MIT, and received a Ph.D. in Cell Biology in 1975. Her professional life includes positions at Harvard University, the University of Massachusetts Medical Center, Cold Spring Harbor, and Children’s Hospital in Boston. During the discovery phase of her career, she published over 70 research articles and reviews. From 1998 to 2003 she was Vice President for Research at Northwestern University in Illinois and from 2003 to 2005 she served as Vice President for Research and Chief Operating Officer of the Whitehead Institute in Cambridge. She joined Cytonome, Inc as Chief Scientific Officer in 2005, became CEO in 2006, and co-founded Cytonome/ST, LLC in 2009. She was appointed to the Board of Transkaryotic Therapies in 2003 and became Chair of the Board in 2005. She is currently on the Board of ATCC and Chair of the Executive Committee.
She is a member of the Hispanic Engineer National Achievement Hall of Fame and a fellow of the Association for Women in Science and the American Association for the Advancement of Science (AAAS). She was named Hispanic Scientist of the Year in 2008 by the Museum of Science and Industry of Tampa, FL. She was a member of the US delegation to the Asian-Pacific Economic Conference-Women and the Economy Forum held in Russia in June 2012. She has served on review committees for the National Institutes of Health and National Science Foundation. She was a member of the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects, the National Research Council Committee on the Structure of NIH, and the congressionally mandated National Science Foundation Committee on Equal Opportunity in Science and Engineering. She was elected to a four year term on the Board of Directors of AAAS in 2001. She is a founding member of the Society for the Advancement of Chicanos and Native Americans in Science (SACNAS) and has been both a board member and vice president of the organization. She is currently serving on the National Academies of Sciences, Engineering, and Medicine standing Committee on Women in Science, Engineering, and Medicine.